Bogus data. Pay-for-play. And even fake news. Illegitimate science has taken several forms. The most notable of all: predatory publishing. But another, less discussed, issue is the problem of predatory medical conferences. And there are costs.
As healthcare moves to an outcomes-based model, Pharma is starting to accept the idea of contracts that tie reimbursement for therapies to patient outcomes
Gene cell therapy, biologics, and other complicated treatments are the wave of the future — where Medical Affairs plays an increasingly important role
If the drug gains full FDA approval in January 2018, it will be the first ever gene cell therapy approved for an inherited disease.